» Articles » PMID: 37659079

TMEM127 Suppresses Tumor Development by Promoting RET Ubiquitination, Positioning, and Degradation

Abstract

The TMEM127 gene encodes a transmembrane protein of poorly known function that is mutated in pheochromocytomas, neural crest-derived tumors of adrenomedullary cells. Here, we report that, at single-nucleus resolution, TMEM127-mutant tumors share precursor cells and transcription regulatory elements with pheochromocytomas carrying mutations of the tyrosine kinase receptor RET. Additionally, TMEM127-mutant pheochromocytomas, human cells, and mouse knockout models of TMEM127 accumulate RET and increase its signaling. TMEM127 contributes to RET cellular positioning, trafficking, and lysosome-mediated degradation. Mechanistically, TMEM127 binds to RET and recruits the NEDD4 E3 ubiquitin ligase for RET ubiquitination and degradation via TMEM127 C-terminal PxxY motifs. Lastly, increased cell proliferation and tumor burden after TMEM127 loss can be reversed by selective RET inhibitors in vitro and in vivo. Our results define TMEM127 as a component of the ubiquitin system and identify aberrant RET stabilization as a likely mechanism through which TMEM127 loss-of-function mutations cause pheochromocytoma.

Citing Articles

Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial.

Liu Y, Li X, Zhang M, Men Y, Wang Y, Zhu X Drug Des Devel Ther. 2025; 19:515-524.

PMID: 39876990 PMC: 11774110. DOI: 10.2147/DDDT.S484310.


Mapping the cancer surface proteome in search of target antigens for immunotherapy.

Di Meo F, Kale B, Koomen J, Perna F Mol Ther. 2024; 32(9):2892-2904.

PMID: 39068512 PMC: 11403220. DOI: 10.1016/j.ymthe.2024.07.019.


Genetic and Molecular Biomarkers in Aggressive Pheochromocytomas and Paragangliomas.

Torresan F, Iacobone C, Giorgino F, Iacobone M Int J Mol Sci. 2024; 25(13).

PMID: 39000254 PMC: 11241596. DOI: 10.3390/ijms25137142.


Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics.

Walker T, Reyes-Alvarez E, Hyndman B, Sugiyama M, Oliveira L, Rekab A Elife. 2024; 12.

PMID: 38687678 PMC: 11060712. DOI: 10.7554/eLife.89100.


Lung Cancer in Never Smokers: Delving into Epidemiology, Genomic and Immune Landscape, Prognosis, Treatment, and Screening.

Cali Daylan A, Miao E, Tang K, Chiu G, Cheng H Lung. 2023; 201(6):521-529.

PMID: 37973682 DOI: 10.1007/s00408-023-00661-3.


References
1.
Toledo R, Burnichon N, Cascon A, Benn D, Bayley J, Welander J . Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 2016; 13(4):233-247. DOI: 10.1038/nrendo.2016.185. View

2.
Tahira T, Ishizaka Y, Itoh F, Sugimura T, Nagao M . Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene. 1990; 5(1):97-102. View

3.
Furlan A, Dyachuk V, Kastriti M, Calvo-Enrique L, Abdo H, Hadjab S . Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla. Science. 2017; 357(6346). PMC: 6013038. DOI: 10.1126/science.aal3753. View

4.
Citterio C, Vichi A, Pacheco-Rodriguez G, Aponte A, Moss J, Vaughan M . Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1. Proc Natl Acad Sci U S A. 2008; 105(8):2877-82. PMC: 2268553. DOI: 10.1073/pnas.0712224105. View

5.
Takaya K, Yoshimasa T, Arai H, Tamura N, Miyamoto Y, Itoh H . Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin. J Mol Med (Berl). 1996; 74(10):617-21. DOI: 10.1007/s001090050065. View